Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Cannabis

Cannabis

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Cannabis
  • Markets
  • News
  • Psychedelics
  • Small Cap

Psychedelics And Treatment-Resistant Depression: Reactions To COMPASS’ Published Results

By Lara Goldstein
November 18, 2:28 PM
(Part two of a four-part series) See previous story in this series: Psychedelics And Treatment-Resistant Depression: An Overview Of COMPASS’ Latest Trial Outcomes

CMPS

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

Molson Coors Says Farewell To Cannabis And Its Partnership With HEXO, Here’s Why

By Jelena Martinovic
November 18, 11:26 AM
Molson Coors Beverages Co. (NYSE: TAP) decided to pull out of two joint ventures, one with cannabis company HEXO Corp.

HEXO

Read More
2 minute read
  • Cannabis
  • Markets
  • News

Hill Street Announces Warrant Extension And Repricing

By Vuk Zdinjak
November 18, 11:18 AM
Hill Street Beverage Company Inc. (OTCPK:HSEEF) (TSXV:HILL) has extended the expiry date and reduced the exercise price of 11.25 million warrants of the company which were originally set to expire on November 18, 20223, after having received the approval of the TSX Venture Exchange to such amendments.

HSEEF

Read More
1 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

Tilray Launches ‘Take Back Control’ Platform To Provide Women With Free Medical Cannabis Resources

By Vuk Zdinjak
November 18, 8:27 AM
Tilray Medical, a medical cannabis division of Tilray Brands, Inc.,(NASDAQ: TLRY) (TSX:TLRY) has launched Take Back Control, a new platform developed to connect women with free reso

TLRY

Read More
2 minute read
  • Cannabis
  • Contracts
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Psychedelics For FXS Symptoms: New Research Contract For Upcoming Phase 2 Clinical Trial

By Lara Goldstein
Today, 2:48 PM
Psychedelics company Wellbeing Digital Sciences Inc. (OTC: KONEF)’s subsidiary KGK Science Inc. has entered into a research services agreement with Canadian-based biotech Nova Mentis Life Science Corp.

KONEF

Read More
3 minute read
  • Cannabis
  • Markets
  • News

RespireRx Signs LOI With Australian CRO For Dronabinol Development For Obstructive Sleep Apnea

By Vuk Zdinjak
Today, 11:21 AM
RespireRx Pharmaceuticals Inc. (OTCPK:RSPI) entered into a letter of intent with an Australia headquartered bespoke clinical research organization focused on cannabinoid and psychedelic clinical research.

RSPI

Read More
2 minute read
  • Cannabis
  • FDA
  • Markets
  • News
  • Penny Stocks

Incannex Initiates BA/BE Clinical Trial Evaluating IHL-42X In Obstructive Sleep Apnoea

By Nina Zdinjak
Today, 10:59 AM
Cannabis and psychedelics-focused Pharma company Incannex Healthcare Limited (NASDAQ: IXHL) (ASX: IHL) initiated a BA/BE study and is targeting submission of an IND application with the FDA in Q1 2023.

IXHL

Read More
1 minute read
  • Biotech
  • Cannabis
  • General
  • Markets
  • News
  • Penny Stocks

Israeli Canna-Tech Co. Teams Up With Another CPG Business, Here Are The Details

By Jelena Martinovic
Today, 10:57 AM
BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) announced on Thursday that it has signed a deal for the provision of software services with an Israeli air conditioning company.

BCAN

Read More
1 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

Xebra Provides Update On The Issuance Of Its Mexican Cannabis Authorizations

By Vuk Zdinjak
Today, 10:48 AM
Xebra Brands Ltd. (OTCQB: XBRAF) (CSE:XBRA) (FSE:9YC), a cannabis company, provided an update on the issuance of its Mexican cannabis authorizations.

CSE:XBRA

Read More
2 minute read
  • Cannabis
  • Markets
  • News

Aelis Farma’s Drug Candidate For the Treatment Of Cognitive Disorders Authorized For The First Trial In People With Down Syndrome

By Vuk Zdinjak
Today, 10:40 AM
Aelis Farma (Paris:AELIS), a clinical stage biopharmaceutical company specializing in the development of treatments for brain diseases, announced positive results from its phase 1 clinical trials in healthy volunteers with its drug candidate AEF0217.

PARIS:AELIS

Posts pagination

Previous 1 … 351 352 353 … 449 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service